SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$5.93
0.01 (0.17%)
▲
5d:
-7.2%
30d:
-30.81%
90d:
-68.97%
HOLD
LOW Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 14, 2026
17d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
26.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $5.93, which is considered oversold relative to its 30-day fair value range of $6.85 to $10.88. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.0) compared to its historical average (28.4). Remarkably, the market is currently pricing in an annual earnings decline of 17.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $5.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+575.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $5.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+575.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.85 -
$10.88
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 575.7% below Wall St target ($40.00)
- CAUTION: Recommendation downgraded due to -7.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$6.85 -
$10.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.77
Resistance Level
$13.00
Current Trend
Strong Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.00
Wall Street Target
$40.00
(+575.7%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
37.2%
Valuation Discount vs History
-17.4% cheaper
PE vs Historical
16.0 vs 28.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.4%
(market-implied from PE analysis)
1-Year Target
$5.33
(-10%)
2-Year Target
$4.80
(-19%)
3-Year Target
$4.32
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→28)
$7.66
(+29%)
📈
Valuation based on Current Earnings
Trailing PE: 6.33 | Current EPS (TTM): $0.94
Bull Case
$3.27
(-45%)
Analyst growth -50.0%, PE expands to 7.0
Base Case
$2.98
(-50%)
Market implied -50.0%, PE stable at 6.3
Bear Case
$4.05
(-32%)
Severe decline -20.0%, PE contracts to 5.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.0 to 28.4
Stabilization Target:
$10.51
(+77.5%)
PE Expansion Potential:
+77.5%
Share & Embed Analysis
Last updated: July 26, 2026 9:01 PM ET
Data refreshes hourly during market hours. Next update: 10:01 PM
Data refreshes hourly during market hours. Next update: 10:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 54 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 47 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$238 | 50 HOLD |
